Euroasian journal of hepato-gastroenterology

Register      Login

VOLUME 12 , ISSUE 2 ( July-December, 2022 ) > List of Articles


Emerging Role and Place of Probiotics in the Management of Pediatric Neurodevelopmental Disorders

Himani Narula Khanna, Sushovan Roy, Aqsa Shaikh, Viswanath Bandi

Keywords : Dysbiosis, Gut-brain axis, Neurodevelopmental disorders, Psychobiotics

Citation Information : Khanna HN, Roy S, Shaikh A, Bandi V. Emerging Role and Place of Probiotics in the Management of Pediatric Neurodevelopmental Disorders. Euroasian J Hepatogastroenterol 2022; 12 (2):102-108.

DOI: 10.5005/jp-journals-10018-1384

License: CC BY-NC 4.0

Published Online: 10-03-2023

Copyright Statement:  Copyright © 2022; The Author(s).


The current decade has witnessed significant developments with the latest therapeutic agents for managing various infectious diseases to complex hemato-oncological conditions, leading to a decrease in morbidity and mortality, while improving the quality of life (QoL), and increasing the life span. Non-communicable diseases (NCDs), which are on the rise across all age-groups, are being driven by unhealthy lifestyles and improved mental health issues. The current therapeutic agents were found to offer only symptomatic relief of varying efficacy and significant adverse effects, leading clinicians to evaluate other options for the management of both neurodevelopmental and neurodegenerative disorders. The role of gut microbiota has emerged as a potential target for the treatment of both neurodegenerative diseases and neurodevelopmental disorders like attention-deficit hyperactivity disorder (ADHD)/autism spectrum disorders (ASD) as a result of the decoding of the human genome and advances in our understanding of the human gut microbiome, including its interactions with the human brain. This review has been undertaken to understand on date level of understanding of human microbiota and towards identifying probiotic strains with proven efficacy and safety. According to recent investigations, several lactobacillus strains, including L. Paracasei 37, L. Planetarium 128, L. reuteri DSM 17938, and Bifidobacterium longum, have been effective in treating children's neurodevelopmental disorders such as ASD and ADHD. Future clinical studies are nonetheless required to confirm the long-term safety and effectiveness of probiotic strains in managing the primary and comorbid symptoms, hence improving patient and family quality of life.

  1. Schön M, Mousa A, Berk M, et al. The potential of carnosine in brain-related disorders: A comprehensive review of current evidence. Nutrients 2019;11(6):1196. DOI: 10.3390/nu11061196.
  2. Liu YW, Liong MT, Chung YE, et al. Effects of Lactobacillus plantarum PS128 on children with autism spectrum disorder in Taiwan: A randomized, double-blind, placebo-controlled trial. Nutrients 2019;11(4):820. DOI: 10.3390/nu11040820.
  3. Rzepka-Migut B, Paprocka J. Efficacy and safety of melatonin treatment in children with autism spectrum disorder and attention-deficit/hyperactivity disorder—a review of the literature. Brain Sciences 2020;10(4): 219. DOI: 10.3390/brainsci10040219.
  4. Chien Y–L, Chou MC, Chiu YN, et al. ADHD-related symptoms and attention profiles in the unaffected siblings of probands with autism spectrum disorder: focus on the subtypes of autism and Asperger's disorder. Molecular Autism 2017;8(1):1–12. DOI: 10.1186/s13229-017-0153-9.
  5. Hodges H, Fealko C, Soares N. Autism spectrum disorder: Definition, epidemiology, causes, and clinical evaluation. Translational Pediatrics 2020;9(Suppl 1):S55–S65. DOI: 10.21037/tp.2019.09.09.
  6. Messaoudi M, Lalonde R, Violle N, et al. Assessment of psychotropic-like properties of a probiotic formulation (lactobacillus helveticus R0052 and bifidobacterium longum R0175) in rats and human subjects. The British Journal of Nutrition 2011;105(5):755–764. DOI: 10.1017/S0007114510004319.
  7. Taylor E, Döpfner M, Sergeant J, et al. European clinical guidelines for hyperkinetic disorder–first upgrade. European Child & Adolescent Psychiatry 2004;13(1):17-30. DOI: 10.1007/s00787-004-1002-x.
  8. Reindal L, Nærland T, Sund AM, et al. The co-occurrence of motor and language impairments in children evaluated for autism spectrum disorder. An explorative study from Norway. Research in Developmental Disabilities 2022;127:104256. DOI: 10.1016/j.ridd.2022.104256.
  9. Guney E, Cetin FH, Iseri E. The role of environmental factors in etiology of attention-deficit hyperactivity disorder. In (Ed.), ADHD. New Directions in Diagnosis and Treatment 2011;13(5):333–344. DOI: 10.1007/s11920-011-0221-3.
  10. Lange KW. Micronutrients and diets in the treatment of attention-deficit/hyperactivity disorder: Chances and pitfalls. Frontiers in Psychiatry 2020;11:102. DOI: 10.3389/fpsyt.2020.00102.
  11. Mueller A, Hong DS, Shepard S, et al. Linking ADHD to the neural circuitry of attention. Trends in Cognitive Sciences 2017;21(6):474–488. DOI: 10.1016/j.tics.2017.03.009.
  12. Faraone SV, Asherson P, Banaschewski T, et al. Attention-deficit/hyperactivity disorder. Nature reviews. Nature Reviews Disease Primers 2015;1:15020. DOI: 10.1038/nrdp.2015.20.
  13. Singh, A, Yeh C J, Verma N, et al. Overview of attention deficit hyperactivity disorder in young children. Health Psychology Research 2015;3(2):2115. DOI: 10.4081/hpr.2015.2115.
  14. Srikantha P, Mohajeri MH. The possible role of the microbiota-gut-brain-axis in autism spectrum disorder. International Journal of Molecular Sciences 2019;20(9):2115. DOI: 10.3390/ijms20092115.
  15. Rosi E, Grazioli S, Villa FM, et al. Use of non-pharmacological supplementations in children and adolescents with attention deficit/hyperactivity disorder: A critical review. Nutrients 2020;12(6):1573. DOI: 10.3390/nu12061573.
  16. Aishworiya R, Valica T, Hagerman R, et al. An update on psychopharmacological treatment of autism spectrum disorder. Neurotherapeutics 2022;19(1):248–262. DOI: 10.1007/s13311-022-01183-1.
  17. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001;292(5519):1115–1118. DOI: 10.1126/science.1058709.
  18. Tanaka M, Nakayama J. Development of the gut microbiota in infancy and its impact on health in later life. Allergology International 2017;66(4):515–522. DOI: 10.1016/j.alit.2017.07.010.
  19. Bergström A, Skov TH, Bahl M I, et al. Establishment of intestinal microbiota during early life: a longitudinal, explorative study of a large cohort of Danish infants. Applied and Environmental Microbiology 2014;80(9):2889–2900. DOI: 10.1128/AEM.00342-14.
  20. Almgren M. Benefits of skin-to-skin contact during the neonatal period: Governed by epigenetic mechanisms? Genes and Diseases 2018;5(1):24–26. DOI: 10.1016/j.gendis.2018.01.004.
  21. Van den Elsen LW, Garssen J, Burcelin R, et al. Shaping the gut microbiota by breastfeeding: The gateway to allergy prevention? Frontiers in Pediatrics 2019;7:47. DOI: 10.3389/fped.2019.00047.
  22. Differding MK, Benjamin-Neelon SE, Hoyo C. Timing of complementary feeding is associated with gut microbiota diversity and composition and short-chain fatty acid concentrations over the first year of life. BMC Microbiology 2020;20(1):1–13. DOI: 10.1186/s12866-020-01723-9.
  23. Westfall S, Lomis N, Kahouli I, et al. Microbiome, probiotics, and neurodegenerative diseases: Deciphering the gut-brain axis. Cellular and Molecular Life Sciences 2017;74(20):3769–3787. DOI: 10.1007/s00018-017-2550-9.
  24. Fattorusso A, Di Genova L, Dell'Isola GB, et al. Autism spectrum disorders and the gut microbiota. Nutrients 2019;11(3):521. DOI: 10.3390/nu11030521.
  25. Khosravi A, Mazmanian SK. Disruption of the gut microbiome as a risk factor for microbial infections. Current Opinion in Microbiology 2013;16(2):221–227. DOI: 10.1016/j.mib.2013.03.009.
  26. Verbeke KA, Boobis AR, Chiodini A, et al. Towards microbial fermentation metabolites as markers for health benefits of prebiotics. Nutrition Research Reviews 2015;28(1):42–66. DOI: 10.1017/S0954422415000037.
  27. MacFabe DF. Enteric short-chain fatty acids: Microbial messengers of metabolism, mitochondria, and mind: Implications in autism spectrum disorders. Microbial Ecology in Health and Disease 2015;26(1):28177. DOI: 10.3402/mehd.v26.28177.
  28. Liu L, Huh JR, Shah K. Microbiota and the gut-brain-axis: Implications for new therapeutic design in the CNS. EBioMedicine 2022;77:103908. DOI: 10.1016/j.ebiom.2022.103908.
  29. Parkin K, Christophersen CT, Verhasselt V, et al. Risk factors for gut dysbiosis in early life. Microorganisms 2021;9(10):2066. DOI: 10.3390/microorganisms9102066.
  30. Gibson GR, Hutkins R, Sanders ME. Expert consensus document: The international scientific association for probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nature Reviews Gastroenterology & Hepatology 2017;14(8):491–502. DOI: 10.1038/nrgastro.2017.75.
  31. Mirzaei R, Bouzari B, Hossein-Fard SR, et al. Role of microbiota-derived short-chain fatty acids in nervous system disorders. Biomedicine & Pharmacotherapy 2021;139:111661. DOI: 10.1016/j.biopha.2021.111661.
  32. Bravo JA, Forsythe P, Chew MV, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proceedings of the national academy of sciences of the United States of America 2011;108(38):16050–16055. DOI: 10.1073/pnas.1102999108.
  33. Silverman JL, Yang M, Lord C, et al. Behavioral phenotyping assays for mouse models of autism. Nature Reviews Neuroscience 2010;11(7):490–502. DOI:
  34. Al-Beltagi M. Autism medical comorbidities. World Journal of Clinical Pediatrics 2012;10(3):15–28. DOI: 10.5409/wjcp.v10.i3.15.
  35. Peralta-Marzal LN, Prince N, Bajic D, et al. The impact of gut microbiota-derived metabolites in autism spectrum disorders. International Journal of Molecular Sciences 2021;22(18):10052. DOI: 10.3390/ijms221810052.
  36. Lee SH, Ahmad SR, Lim YC, et al. The use of probiotic therapy in metabolic and neurological diseases. Frontiers in Nutrition 2022;9:887019. DOI: 10.3389/fnut.2022.887019.
  37. Preidis GA, Saulnier DM, Blutt SE, et al. Host response to probiotics determined by the nutritional status of rotavirus-infected neonatal mice. Journal of Pediatric Gastroenterology and Nutrition 2012;55(3):299–307. DOI: 10.1097/MPG.0b013e31824d2548.
  38. Messaoudi M, Lalonde R, Violle N, et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. The British Journal of Nutrition 2011;105(5):755–764. DOI: 10.1017/S0007114510004319.
  39. Jadrešin O, Sila S, Trivić I, et al. Lactobacillus reuteri DSM 17938 is effective in the treatment of functional abdominal pain in children: Results of the double-blind randomized study. Clinical Nutrition 2020;39(12): 3645–3651. DOI: 10.1016/j.clnu.2020.04.019.
  40. Wall R, Cryan JF, Ross P, et al. Bacterial neuroactive compounds produced by psychobiotics. Advances in Experimental Medicine and Biology 2014;817:221–239. DOI: 10.1007/978-1-4939-0897-4_10.
  41. Sudo N. The hypothalamic-pituitary-adrenal axis and gut microbiota: A target for dietary intervention? In the gut-brain axis. Academic Press 2016;293–304. DOI:
  42. Cheng LH, Liu YW, Wu CC, et al. Psychobiotics in mental health, neurodegenerative and neurodevelopmental disorders. Journal of Food and Drug Analysis 2019;27(3):632–648. DOI: 10.1016/j.jfda.2019.01.002.
  43. Parracho HM, Gibson GR, Knott F, et al. A double-blind, placebo-controlled, crossover-designed probiotic feeding study in children diagnosed with autistic spectrum disorders. J. Clin. Med. 2022, 11(18), 5263.
  44. Santocchi E, Guiducci L, Prosperi M, et al. Effects of probiotic supplementation on gastrointestinal, sensory and core symptoms in autism spectrum disorders: A randomized controlled trial. Frontiers Psychiatry 2020;11:550593. DOI: 10.3389/fpsyt.2020.550593.
  45. Pärtty A, Kalliomäki M, Wacklin P, et al. A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: A randomized trial. Pediatric Research 2015;77(6):823–828. DOI: 10.1038/pr.2015.51.
  46. Wang LJ, Yang CY, Kuo HC, et al. Effect of bifidobacterium bifidum on clinical characteristics and gut microbiota in attention-deficit/hyperactivity disorder. Journal of Personalized Medicine 2022;12(2):227. DOI: 10.3390/jpm12020227.
  47. Hemalatha R, Ouwehand AC, Saarinen MT, et al. Effect of probiotic supplementation on total lactobacilli, bifidobacteria, and short-chain fatty acids in 2–5-year-old children. Microbial Ecology in Health and Disease 2017;28(1):1298340. DOI: 10.1080/16512235.2017.1298340.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.